Intended for healthcare professionals

Hidradenitis suppurativa

Jan von der Werth
Hidradenitis suppurativa was first described by the French physician Velpeau in 1839. Some patients may feel that over the past 160 years we have not made much progress in our attempts to successfully treat this condition. Is this so? Have we really failed to advance significantly on this disease despite our powerful array of modern medicaments and surgical techniques? I guess in the eyes of many who suffer from HS the answer would be: yes. Hands up all those who feel comfortable when confronted with a hidradenitis patient. So, what is the cause for this lack of progress and do we really have so little to offer for this condition?
Dermatology in practice 2001; 9(3): 22–25
To continue reading this article, please sign in or register.

Dermatology in practice was previously supported by Wyeth from 2008 to 2010, by Wyeth and Serono in 2007, by Wyeth and Shire from 2005 to 2006, by Medlock Medical in 2004 and by SSL International from 2001 to 2003.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the publisher, Editor or Editorial Board. Accordingly the publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Dermatology in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2021 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 0262-5504 (Print) ISSN 2049-8446 (Online)